You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


Drug Therapy, Other

Citations 491-500 of 1036 total displayed.

Past content (since Mar 1998):

Special Communications
Guest Authorship and Ghostwriting in Publications Related to Rofecoxib: A Case Study of Industry Documents From Rofecoxib Litigation
Joseph S. Ross; Kevin P. Hill; David S. Egilman; Harlan M. Krumholz
JAMA 2008; 299: 1800-1812. [Abstract] [Full text] [PDF]  

Special Communications
Reporting Mortality Findings in Trials of Rofecoxib for Alzheimer Disease or Cognitive Impairment: A Case Study Based on Documents From Rofecoxib Litigation
Bruce M. Psaty; Richard A. Kronmal
JAMA 2008; 299: 1813-1817. [Abstract] [Full text] [PDF] [ JAMA Report Video ]  

Editorials
Impugning the Integrity of Medical Science: The Adverse Effects of Industry Influence
Catherine D. DeAngelis; Phil B. Fontanarosa
JAMA 2008; 299: 1833-1835. [Extract] [Full text] [PDF]  

Capitol Health Call
Surrogate End Points Queried
Mike Mitka
JAMA 2008; 299: 1657. [Extract] [Full text] [PDF]  

Original Contributions
Chemoembolization Combined With Radiofrequency Ablation for Patients With Hepatocellular Carcinoma Larger Than 3 cm: A Randomized Controlled Trial
Bao-Quan Cheng; Chong-Qi Jia; Chun-Tao Liu; Wei Fan; Qing-Liang Wang; Zong-Li Zhang; Cui-Hua Yi
JAMA 2008; 299: 1669-1677. [Abstract] [Full text] [PDF] [ NOTICE OF RETRACTION ]  

Commentaries
When Should Data and Safety Monitoring Committees Share Interim Results in Cardiovascular Trials?
Jeffrey S. Borer; David J. Gordon; Nancy L. Geller
JAMA 2008; 299: 1710-1712. [Extract] [Full text] [PDF]  

Editorials
Expanding the Treatment Options for Hepatocellular Carcinoma: Combining Transarterial Chemoembolization With Radiofrequency Ablation
Andrew X. Zhu; Ghassan K. Abou-Alfa
JAMA 2008; 299: 1716-1718. [Extract] [Full text] [PDF]  

Editorials
The Great Debate of 2008—How Low to Go in Preventive Cardiology?
Eric D. Peterson; Tracy Y. Wang
JAMA 2008; 299: 1718-1720. [Extract] [Full text] [PDF]  

Medical News & Perspectives
HIV Prevention Studies Yield Mixed Results
Joan Stephenson
JAMA 2008; 299: 1529-1530. [Extract] [Full text] [PDF]  

Letters
Effect of Aspirin Use on Thiazolidinediones and Cardiovascular Events—Reply
Lorraine L. Lipscombe; David A. Alter
JAMA 2008; 299: 1539-a-1540-a. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104

 Collections
 •Sign up for Topic Collection Alerts
 •Topic Collections Home
 • Show Drug Therapy, Other
 collections from JAMA & Archives Journals.
 •Related collections:
  •Drug Therapy
  •Adherence
  •Adverse Effects
  •Medication Error
  •Pediatric Dosing
  •Drug Therapy, Other
Advertisement





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.